Screener
Tenet Healthcare THC Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 20.8%+3.0pp | 18%+0.4pp | 16.5%-12.4pp | 16.7%-11.3pp | 17.8%-7.8pp | |
| Net margin | 14.6%+3.0pp | 12.4%+0.9pp | 11.1%-8.6pp | 11%-7.8pp | 11.6%-5.3pp | |
| Returns | ||||||
| Return on equity | 75.5%+9.1pp | 58.9%-2.7pp | 56.4%-84.2pp | 58.5%-90.6pp | 66.4%-80.3pp | |
| Return on invested capital | 30%+3.7pp | 26.1%+0.7pp | 21.7%-14.5pp | 25.7%-15.8pp | 26.3%-10.4pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×0.0× | 0.7×0.0× | 0.7×0.0× | 0.7×0.0× | 0.7×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.4×-0.3× | 1.4×-0.4× | 1.8×0.0× | 1.7×+0.1× | 1.7×+0.3× | |
| Leverage | ||||||
| Debt-to-equity | 2.9×-0.7× | 2.8×-0.4× | 3.5×0.0× | 3.3×-0.1× | 3.5×-0.2× | |
| Net debt / EBITDA | 2.1×-0.3× | 2.2×-0.1× | 2.8×+1.0× | 2.4×+1.1× | 2.4×+0.7× | |
| Per Share | ||||||
| Book value per share | $55.48+35.8% | $54.96+24.9% | $46.46+9.0% | $45.30+14.2% | $40.84+15.7% | |
| Valuation | ||||||
| Market capitalization | $21.08B+49.8% | $16.41B+28.3% | $17.46B+45.5% | $17.94B+12.6% | $15.93B+22.6% | |
| Price / earnings | 6.6×+0.8× | 6.2×+0.8× | 7.4×+4.4× | 7.8×+3.8× | 6.6×+3.0× | |
| Price / sales | 1×+0.3× | 0.8×+0.1× | 0.8×+0.2× | 0.9×+0.1× | 0.8×+0.1× | |
| Price / book | 4.5×+0.8× | 3.4×+0.3× | 4.1×+1.3× | 4.5×+0.3× | 4.2×+0.5× | |
| EV / EBITDA | 5.9×+0.4× | 5.6×+0.4× | 6.8×+3.2× | 6.6×+2.9× | 5.9×+2.2× |
FAQ
- Where do Tenet Healthcare's ratios come from?
- Every ratio is computed from Tenet Healthcare's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
